Patent details

Basic Information

Publication number:

EP2790702

PCT Application Number:

IB2012002900

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP128309002

PCT Publication Number:

WO2013088243

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOSITIONS OF BUPRENORPHINE AND MU-OPIOID RECEPTOR ANTAGONISTS

French Title of Invention:

COMPOSITIONS DE BUPRÉNORPHINE ET D'ANTAGONISTES DE RÉCEPTEUR DES OPIOÏDES MU

German Title of Invention:

ZUSAMMENSETZUNGEN AUS BUPRENORPHIN UND MU-OPIOID-REZEPTORANTAGONISTEN

SPC Number:

Dates

Filing date:

14/12/2012

Grant date:

01/04/2020

EP Publication Date:

22/10/2014

PCT Publication Date:

20/06/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/04/2020

EP B1 Publication Date:

01/04/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/12/2020

Expiration date:

14/12/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/03/2020

 

 

Name:

Alkermes Pharma Ireland Limited

Address:

Connaught House 1 Burlington Road, Dublin 4, Ireland (IE)

Inventor

1

Name:

EHRICH, Elliot

Address:

United States (US)

2

Name:

DEAVER, Daniel

Address:

United States (US)

Priority

Priority Number:

201161576233 P

Priority Date:

15/12/2011

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/485; A61P 25/04; A61P 25/22; A61P 25/24;

Publication

European Patent Bulletin

Issue number:

202014

Publication date:

01/04/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages